Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 547.00M | 1.19B | 1.74B | 2.18B | 418.00M |
| Total Depreciation and Amortization | -397.00M | 387.00M | 380.00M | 373.00M | -336.00M |
| Total Amortization of Deferred Charges | 803.00M | -- | -- | -- | 734.00M |
| Total Other Non-Cash Items | -345.00M | 309.00M | 149.00M | 246.00M | -92.00M |
| Change in Net Operating Assets | -524.00M | -750.00M | -218.00M | -1.79B | -18.00M |
| Cash from Operations | 84.00M | 1.14B | 2.05B | 1.02B | 706.00M |
| Capital Expenditure | -293.00M | -360.00M | -267.00M | -196.00M | -322.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 33.00M | 55.00M | -- | -- | -3.69B |
| Divestitures | -- | -54.00M | 50.00M | 4.00M | -36.00M |
| Other Investing Activities | 724.00M | -865.00M | -470.00M | 295.00M | 2.41B |
| Cash from Investing | 464.00M | -1.22B | -687.00M | 103.00M | -1.64B |
| Total Debt Issued | 1.56B | 3.54B | 261.00M | 836.00M | 5.04B |
| Total Debt Repaid | -542.00M | -2.07B | 110.00M | -1.37B | -1.45B |
| Issuance of Common Stock | 58.00M | 0.00 | -- | 23.00M | 16.00M |
| Repurchase of Common Stock | -472.00M | -867.00M | -297.00M | -1.00B | -1.81B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -377.00M | -381.00M | -385.00M | -386.00M | -373.00M |
| Other Financing Activities | 12.00M | 21.00M | 3.00M | -14.00M | -7.00M |
| Cash from Financing | 236.00M | 243.00M | -308.00M | -1.91B | 1.41B |
| Foreign Exchange rate Adjustments | -6.00M | -1.00M | 1.00M | 1.00M | -8.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -46.00M |
| Net Change in Cash | 778.00M | 153.00M | 1.06B | -788.00M | 422.00M |